Study guide
8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
Medical Council of Canada Qualifying Examination Part I MCCQE Part I
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Blueprint & Canadian Medical Practice
1.1 MCCQE Part I Format, Scoring (439 Scale), & Strategy 1.2 The MCC Blueprint Matrix: Dimensions of Care & Physician Activities 1.3 Canadian Healthcare System, CanMEDS Roles, & Interprofessional Care 1.4 Evidence-Based Medicine, Study Design, & Clinical Statistics
2 Chapter 2: Population Health, Health Promotion & Preventive Care
2.1 Canadian Task Force on Preventive Health Care (CTFPHC) Screening Guidelines 2.2 Immunization Schedules (NACI) & Vaccine-Preventable Diseases across Lifespan 2.3 Disease Prevention, Lifestyle Counselling, & Harm Reduction 2.4 Outbreak Management, Disease Surveillance, & Infection Control 2.5 Occupational, Environmental, & Travel Medicine in Canada
3 Chapter 3: Internal Medicine — Cardiovascular & Respiratory Systems
3.1 Hypertension Canada 2020/2025 Guidelines, Dyslipidemia, & Primary Prevention 3.2 Ischemic Heart Disease, Acute Coronary Syndromes, & Heart Failure Management 3.3 Arrhythmias, Valvular Heart Disease, & Infective Endocarditis 3.4 Asthma, COPD, & Respiratory Failure (CTS Guidelines) 3.5 Thromboembolic Disease (DVT/PE), Pneumonia, & Pleural Effusions
4 Chapter 4: Internal Medicine — GI, Endocrine, Renal & Hematology/Oncology
4.1 Gastrointestinal Disorders, Acute Abdomen, & Liver/Biliary Disease 4.2 Diabetes Canada 2020/2025 Guidelines & Glycemic Management 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances 4.4 Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), & Nephrology 4.5 Hematology, Anemia Evaluation, Transfusion Medicine, & Common Cancers
5 Chapter 5: General Surgery, Orthopedics, & Emergency Care
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications 5.2 Trauma Management (ATLS Protocol) & Burns 5.3 Acute Surgical Conditions (Appendicitis, Cholecystitis, Bowel Obstruction) 5.4 Fractures, Dislocations, Joint Pain, & Musculoskeletal Emergencies 5.5 Vascular Emergencies, Wound Care, & Shock Recognition
6 Chapter 6: Pediatrics & Adolescent Health
6.1 Pediatric Growth, Developmental Milestones, & Well-Child Examinations 6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies 6.3 Pediatric Respiratory Emergencies (Croup, Bronchiolitis, Asthma) 6.4 Common Pediatric Infections, Exanthems, & Fever of Unknown Origin 6.5 Pediatric Abdominal Pain, Dehydration, & Fluid Management
7 Chapter 7: Obstetrics & Gynecology
7.1 Routine Antepartum Care, Screening, & Prenatal Diagnosis (SOGC Guidelines) 7.2 Medical Complications of Pregnancy (Preeclampsia, Gestational Diabetes, Infections) 7.3 Labor, Intrapartum Management, & Postpartum Complications/Hemorrhage 7.4 Abnormal Uterine Bleeding, Gynecologic Infections, & Contraception/Menopause 7.5 Gynecologic Oncology & Pelvic Mass Evaluation
8 Chapter 8: Psychiatry & Mental Health
8.1 Mood Disorders (Depression, Bipolar) & Suicide Risk Assessment 8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders 8.3 Psychotic Disorders & Schizophrenia Management 8.4 Substance Use Disorders, Withdrawal Syndromes, & Harm Reduction 8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
9 Chapter 9: Neurology, Rheumatology, & Dermatology
9.1 Acute Stroke, TIA, & Neurovascular Emergencies 9.2 Headaches, Seizures, Movement Disorders, & Neuromuscular Disease 9.3 Inflammatory Arthritides (RA, Gout, SpA) & Systemic Autoimmune Diseases (SLE, Vasculitis) 9.4 Common Dermatologic Conditions, Cutaneous Manifestations of Systemic Disease, & Skin Cancers 9.5 Musculoskeletal Soft Tissue Injuries, Back Pain, & Physical Medicine
10 Chapter 10: Legal, Ethical, & Professional Behaviours in Canadian Practice
10.1 Informed Consent, Capacity Assessment, & Substitute Decision-Making (CMPA) 10.2 Medical Confidentiality, Privacy Laws (PIPEDA/PHIPA), & Disclosure of Harm 10.3 CMA Code of Ethics, Professionalism, & Physician Health/Boundary Issues 10.4 Mandatory Reporting (Child/Elder Abuse, Driving Safety, Fitness to Practice) & Quality/Safety
8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
Key Takeaways Explain This Topic AI
ADHD diagnosis requires >=6 symptoms of inattention and/or hyperactivity-impulsivity present before age 12 across >=2 settings; first-line pharmacotherapy consists of stimulant medications (methylphenidate, amphetamines).
Postpartum Blues is mild, self-limiting affective disturbance peaking 3-5 days postpartum and resolving within 2 weeks, whereas Postpartum Psychosis is a medical emergency requiring urgent psychiatric hospitalization.
Delirium is an acute, fluctuating disturbance in attention and awareness caused by underlying medical illness or toxicity, diagnosed using the Confusion Assessment Method (CAM).
Non-pharmacological environmental interventions are first-line for delirium management; low-dose atypical antipsychotics (e.g., haloperidol or quetiapine) are reserved exclusively for severe agitation endangering safety.
Lewy Body Dementia is characterized by visual hallucinations, parkinsonism, REM sleep behavior disorder, and extreme sensitivity to antipsychotics (neuroleptics can precipitate severe extrapyramidal crisis or death).
Last updated: July 2026
8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
Psychiatric care across the lifespan requires tailored diagnostic frameworks and specialized management strategies for pediatric, perinatal, and geriatric populations.
- Pediatric Psychiatry
- Attention-Deficit/Hyperactivity Disorder (ADHD)
Diagnostic Criteria: Persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning, with ≥ 6 \ge 6 ≥ 6 symptoms present before age 12 across ≥ 2 \ge 2 ≥ 2 settings (e.g., home and school) for ≥ 6 \ge 6 ≥ 6 months.
Treatment Hierarchy:
First-Line Pharmacotherapy: Stimulants — Methylphenidate-based (e.g., Concerta, Ritalin) or Amphetamine-based (e.g., Vyvanse, Adderall) compounds. Block dopamine and norepinephrine reuptake.
Monitoring Requirements: Height, weight (risk of appetite suppression and growth delay), blood pressure, and heart rate at baseline and follow-up.
Second-Line / Non-Stimulant Options: Atomoxetine (selective SNRI), Guanfacine XR , or Clonidine (alpha-2 adrenergic agonists; useful if tic co-morbidity or severe insomnia).
Autism Spectrum Disorder (ASD)
Characterized by persistent deficits in social communication and interaction across multiple contexts, alongside restricted, repetitive patterns of behavior , interests, or activities. Early behavioral intervention (Applied Behavior Analysis - ABA) is pivotal.
Disruptive Behavior Disorders
Oppositional Defiant Disorder (ODD): Pattern of angry/irritable mood, argumentative/defiant behavior, or vindictiveness lasting ≥ 6 \ge 6 ≥ 6 months toward authority figures without severe violation of societal norms.
Conduct Disorder (CD): Repetitive pattern of behavior violating basic rights of others or major age-appropriate societal norms (aggression to people/animals, destruction of property, deceitfulness/theft, serious rule violations). Precursor to Antisocial Personality Disorder (diagnosed only after age 18).
Perinatal Psychiatry
Perinatal mood disturbances represent a spectrum ranging from transient emotional lability to life-threatening emergencies.
Condition Onset & Duration Clinical Features & Risk Profile Management Strategy
Postpartum Blues Onset 2–3 days postpartum; peaks at day 5; resolves within 2 weeks . Mild mood swings, tearfulness, irritability, anxiety. Affects up to 80% of mothers. Functional impairment absent. Reassurance, psychoeducation, sleep hygiene, support from partner/family.
Postpartum Depression (PPD) Onset within 4 weeks postpartum (or during pregnancy); lasts months if untreated. Major depressive episode (SIGECAPS), intense anxiety, feelings of inadequacy, guilt regarding infant care. Screen with Edinburgh Postnatal Depression Scale (EPDS) . Psychotherapy (CBT) for mild-moderate; Sertraline preferred for moderate-severe (low excretion into breast milk).
Postpartum Psychosis Medical Emergency! Onset within 1–2 weeks postpartum. Rapid onset of delirium-like confusion, severe mood lability, delusions (often involving the baby, e.g., infant is possessed), command hallucinations. Immediate psychiatric hospitalization. High risk of infanticide or suicide. Antipsychotics + Mood Stabilizers. Electroconvulsive Therapy (ECT) highly effective.
Geriatric Psychiatry & Neurocognitive Disorders
Differentiating among Delirium, Dementia, and Depression ("Pseudodementia") is a cornerstone of geriatric evaluation on the MCCQE Part I.
Delirium: Diagnosis & Evidence-Based Management
Delirium is an acute, fluctuating decline in attention and awareness secondary to an underlying medical etiology.
Diagnostic Criteria — Confusion Assessment Method (CAM):
Diagnosis requires the presence of Features 1 AND 2 , plus EITHER Feature 3 OR 4 :
Acute Onset and Fluctuating Course: Change in baseline mental status, fluctuating severity.
Inattention: Difficulty focusing, sustaining, or shifting attention.
Disorganized Thinking: Rambling, irrelevant, or incoherent speech.
Altered Level of Consciousness: Hyperalert, lethargic, stuporous, or comatose. Common Etiologies of Delirium (I WATCH CONFUSED):
- I - Infection (UTI, Pneumonia)
- W - Withdrawal (Alcohol, Benzodiazepines)
- A - Acute Metabolic (Electrolytes, Hypoglycemia)
- T - Trauma (Subdural hematoma, Hip fracture)
- C - CNS Pathology (Stroke, Encephalopathy)
- H - Hypoxia / Hypercapnia
- C - Constipation / Urinary Retention
- O - Oxygen Deficiency
- N - Neoplasm
- F - Fluid/Electrolyte Balance
- U - Uremia / Renal Failure
- S - Sepsis / Severe Pain
- E - Endocrine (Thyroid, Adrenal)
- D - Drugs (Anticholinergic, Sedatives, Opioids)
Management Strategy:
First-Line: Non-pharmacological Environmental Interventions — Frequent reorientation, daylight exposure, restoring visual/hearing aids, early mobilization, hydration, minimizing sleep interruptions.
Pharmacotherapy: Reserved ONLY for severe agitation or psychotic symptoms that threaten patient/staff safety. Low-dose Haloperidol (0.5–1.0 mg PO/IM) or short-acting SGA (Quetiapine, Risperidone).
Contraindication: Avoid Benzodiazepines in delirium, as they worsen cognitive confusion and disinhibition (EXCEPT in cases of alcohol or benzodiazepine withdrawal).
Major Neurocognitive Disorders (Dementia Spectrum) Differential Diagnosis of Dementia Types:
- Alzheimer's Disease: Insidious memory decline, amyloid/tau pathology
- Vascular Dementia: Stepwise decline, focal neuro deficits, cardiovascular risk factors
- Lewy Body Dementia: Visual hallucinations, REM sleep disorder, Parkinsonism, EXTREME neuroleptic sensitivity
- Frontotemporal Dementia: Early personality/behavioral changes or language impairment (<65 years)
- Key Clinical Features & Treatments
Alzheimer's Disease: Most common cause. Insidious memory impairment followed by executive dysfunction.
Treatment: Cholinesterase Inhibitors (Donepezil, Rivastigmine, Galantamine) for mild-to-moderate; Memantine (NMDA receptor antagonist) for moderate-to-severe.
Vascular Dementia: Second most common. Stepwise cognitive decline linked to cerebrovascular accidents/TIA.
Treatment: Vascular risk factor optimization (hypertension, lipid control, antiplatelet therapy).
Dementia with Lewy Bodies (DLB): Fluctuating cognition, recurrent detailed visual hallucinations , spontaneous Parkinsonism, and REM sleep behavior disorder.
CRITICAL WARNING: Extreme Sensitivity to Antipsychotics. Administration of neuroleptics can trigger life-threatening rigidity, fever, or profound coma. If severe psychosis requires treatment, low-dose Quetiapine or Pimavanserin is preferred with extreme caution.
Frontotemporal Dementia (FTD / Pick's Disease): Early onset (age 50–60). Early loss of social inhibitions, apathy, hyperorality, loss of empathy, or progressive aphasia. Relative preservation of memory early on.